HEALTH

Survey finds concerns over newborns keeping parents up at night

BY Michael Johnsen
PROVO, Utah – According to a new survey from Owlet Baby Care, makers of the Owlet Smart Sock, only 5% of parents of newborns to babies six months old are getting the recommended eight hours of sleep a night. As many as 43% report only getting an average of one to three hours of uninterrupted sleep per night, and 17% of moms report getting a poor night sleep every single night of the week due to their newborn. 
 
"Owlet conducted this survey to shed light on the sleep related issues that parents of newborns face, especially in the first six months," stated Kurt Workman, CEO Owlet Baby Care. "Many of us at Owlet are parents to newborns, so we understand first-hand how having a newborn can have a major impact on parents' ability to get a good night sleep. While striving for a solid eight hours when you have a newborn is pretty unrealistic, we developed our safe sleep system to provide parents with peace of mind while their baby is sleeping so they can worry a little less and get more sleep."
 
Although a majority of parents share night time responsibilities, moms are getting up far more regularly. In fact, 32% of moms report that their spouse or partner never get out of bed to check on baby at night, while only 7% of dads report that mom never got out of bed. 
 
Aside from their newborn keeping them up at night, new parents report a variety of activities and concerns preventing them from getting sleep, including concerns that their newborn is not sleeping well. For this, Owlet Baby Care features the Owlet Baby Monitor, a device that leverages pulse oximetry, the same technology used in hospitals, miniaturized into a baby sock designed to alert parents if their baby's oxygen levels and heart rate are out of range. 
 
With unintentional suffocation a leading cause of injury death among U.S. children under the age of one, moms and dads can rest easy knowing the Owlet Monitor silently watching over their little one.
 
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

H.Hutson says:
May-14-2016 10:26 am

The owlet really does help one get rest, I have used it for about a year and it was the best baby monitor investment I have ever made!!! It is my saving grace, my sleep in a little sock my baby wears, no more staying up and staring at the baby to make sure he kept breathing.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Me+My battles digestive issues with two new dietary enzyme supplements

BY Michael Johnsen

 
 
DOVER, Del. – Me+My on Monday announced the introduction of two new products, Digest Result and Gluten Assist, which are dietary enzyme supplements that simultaneously provide instant relief for digestive discomfort in addition to long-term maintenance to optimize digestive health. 
 
Digest Results helps aid overall digestion and Gluten Assist specifically targets gluten and carbohydrates to make them easier to digest for those who have a non-celiac gluten sensitivity.
 
Me+My Digest Results and Gluten Assist formulas are available in 12 and 30 count sizes. The suggested retail prices are $4.97 and $9.97 respectively.
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

GNC board explores possible sale of company

BY Michael Johnsen
PITTSBURGH – GNC Holdings on Monday announced that its board of directors has commenced a review of a wide range of strategic and financial alternatives to increase shareholder value, incuding a possible sale of the company. 
 
The review will include a thorough evaluation of the company's current operating plan, as well as potential value maximizing alternatives such as accelerated refranchising strategies, capital structure optimization, partnerships and other value-creating collaborations. The board is working with Goldman, Sachs as financial advisor and Wachtell, Lipton, Rosen & Katz as legal advisor to assist in the process.
 
"The board is committed to increasing shareholder value. After careful consideration, including discussions with a range of shareholders, we believe it is an appropriate time to undertake a comprehensive review of the company's strategic and financial alternatives," stated Michael Hines, GNC chairman. "We are in the early stages of a broad review and will take the time we need to thoroughly evaluate our opportunities to achieve the best result for our shareholders, business partners and associates. While the review is ongoing, GNC will continue to act with the necessary urgency to deliver improved financial performance by addressing our near-term challenges and continuing to execute our strategic initiatives."
 
There can be no assurance that this review will result in any specific action, or any assurance as to its outcome or timing. The company does not intend to discuss or disclose further developments related to its review unless and until the board has approved a specific action or otherwise determined that further disclosure is appropriate.
 
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?